SUBJECTS : Translational Oncology | Cancer | Genetics | Endocrinology | Tumou
Translational Oncology: 2024, vol: 39, issue:
- 1)- Yuncang Yuan, Jiawei Fan, Dandan Liang, Shijie Wang, Xu Luo, Yongjie Zhu, Nan Liu, Tingxiu Xiang, Xudong Zhao. Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. Translational oncology. 2024, 39: 101803
Cited : 7Read More - 2)- Han Gong, PeiHe Zhang, Xingming Hu, Bin Zhang. Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer. Translational oncology. 2024, 39: 101808Cited : 1Read More
- 3)- Jing Yang, Yue Cheng, Yan Nie, Bole Tian, Jing Huang, Rixiang Gong, Zhihui Li, Jingqiang Zhu, Yanping Gong. TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway. Translational oncology. 2024, 39: 101809Cited : 1Read More
- 4)- Zhiying Shao, Xueting Chen, Hui Qiu, Muchen Xu, Xin Wen, Ziqin Chen, Zhengyang Liu, Xin Ding, Longzhen Zhang. CircNEK6 promotes the progression of pancreatic ductal adenocarcinoma through targeting miR-503/CCND1 axis. Translational oncology. 2024, 39: 101810Cited : 2Read More
- 5)- Chu-di Zhang, Li-Hong Jiang, Xue Zhou, Yong-Ping He, Ye Liu, Dong-Ming Zhou, Yao Lv, Ben-Qing Wu, Zheng-Yan Zhao. Synergistic antitumor efficacy of rMV-Hu191 and Olaparib in pancreatic cancer by generating oxidative DNA damage and ROS-dependent apoptosis. Translational oncology. 2024, 39: 101812Cited : 2Read More
- 6)- Giovanni Marchi, Anna Rajavuori, Mai T N Nguyen, Kaisa Huhtinen, Sinikka Oksa, Sakari Hietanen, Sampsa Hautaniemi, Johanna Hynninen, Jaana Oikkonen. Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence. Translational oncology. 2024, 39: 101814Cited : 1Read More
- 7)- Xiaorui Wang, Na Li, Minying Zheng, Yongjun Yu, Shiwu Zhang. Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer. Translational oncology. 2024, 39: 101815Cited : 3Read More
- 8)- Zhongqiang Qin, Fangquan Zhu, Bo Xie, Yang Zhang, Mu Yuan, Peipei Yang, Lan Zhang, Jianzhu Wei, Ziyi Zhu, Zhen Qian, Zhaoying Wang, Longfei Fan, Shuaishuai Xu, Yulin Tan, Jingyu Qian. Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma. Translational oncology. 2024, 39: 101816Cited : 0Read More
- 9)- Shuo Xu, Qing-Zhang Tuo, Jie Meng, Xiao-Lei Wu, Chang-Long Li, Peng Lei. Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway. Translational oncology. 2024, 39: 101817Cited : 2Read More
- 10)- Pedro De Marchi, Leticia Ferro Leal, Luciane Sussuchi da Silva, Rodrigo de Oliveira Cavagna, Flavio Augusto Ferreira da Silva, Vinicius Duval da Silva, Eduardo Ca da Silva, Augusto O Saito, Vladmir C Cordeiro de Lima, Rui Manuel Reis. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Translational oncology. 2024, 39: 101818Cited : 2Read More
- 11)- Chuanhui Chen, Mengzhi Wan, Xiong Peng, Qing Zhang, Yu Liu. GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: Evidence from high-throughput sequencing. Translational oncology. 2024, 39: 101819Cited : 2Read More
- 12)- Hana Q Sadida, Alanoud Abdulla, Sara Al Marzooqi, Sheema Hashem, Muzafar A Macha, Ammira S Al-Shabeeb Akil, Ajaz A Bhat. Epigenetic modifications: Key players in cancer heterogeneity and drug resistance. Translational oncology. 2024, 39: 101821Cited : 12Read More
- 13)- Niyati Piplani, Tanusri Roy, Neha Saxena, Shamik Sen. Bulky glycocalyx shields cancer cells from invasion-associated stresses. Translational oncology. 2024, 39: 101822Cited : 5Read More
- 14)- Jin-Hao Yu, Jia-Nan Tan, Guang-Yu Zhong, Lin Zhong, Dong Hou, Shuai Ma, Peng-Liang Wang, Zhi-Hong Zhang, Xu-Qiang Lu, Bin Yang, Sheng-Ning Zhou, Fang-Hai Han. Hsa_circ_0020134 promotes liver metastasis of colorectal cancer through the miR-183-5p-PFN2-TGF-β/Smad axis. Translational oncology. 2024, 39: 101823Cited : 1Read More
- 15)- Bangquan Chen, Maladho Tanta Diallo, Yue Ma, Wenhao Yu, Qing Yao, Shuyang Gao, Yantao Yu, Qiannan Sun, Yong Wang, Jun Ren, Daorong Wang. Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation. Translational oncology. 2024, 39: 101824Cited : 2Read More
- 16)- Junping Li, Hong Hu, Jinping He, Yuling Hu, Manting Liu, Bihui Cao, Dongni Chen, Xiaodie Ye, Jian Zhang, Zhiru Zhang, Wen Long, Hui Lian, Deji Chen, Likun Chen, Lili Yang, Zhenfeng Zhang. Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer. Translational oncology. 2024, 39: 101825Cited : 0Read More
- 17)- Ting-Wei Wang, Heng-Sheng Chao, Hwa-Yen Chiu, Chia-Feng Lu, Chien-Yi Liao, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen, Yu-Te Wu. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors. Translational oncology. 2024, 39: 101826Cited : 6Read More
- 18)- Qiliang Peng, Jialong Tao, Yingjie Xu, Yi Shen, Yong Wang, Yang Jiao, Yiheng Mao, Yaqun Zhu, Yulong Liu, Ye Tian. Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. Translational oncology. 2024, 39: 101828Cited : 0Read More
- 19)- Zhai Cai, Songsheng Wang, Huabin Zhou, Ding Cao. Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer. Translational oncology. 2024, 39: 101829Cited : 1Read More
- 20)- Caiyan Jia, Qian Xu, Lu Zhao, Fanming Kong, Yingjie Jia. Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis. Translational oncology. 2024, 39: 101832Cited : 2Read More
- 21)- Zhiqin Lu, Yali Yi, Linxiao Wang, Yuxi Luo, Daya Luo, Le Xiong, Yun Shu, Hui Luo, Jing Li, Wufu Zhu, Zhimin Zeng, Anwen Liu. Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors. Translational oncology. 2024, 39: 101834Cited : 0Read More
- 22)- Madison Catalanotto, Joel Markus Vaz, Camille Abshire, Reneau Youngblood, Min Chu, Herbert Levine, Mohit Kumar Jolly, Ana-Maria Dragoi. Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal transition plasticity (EMP). Translational oncology. 2024, 39: 101837Cited : 1Read More
- 23)- Mohsen Bagheri, Mohammad Arad Zandieh, Mahshid Daryab, Seyedeh Setareh Samaei, Sarah Gholami, Parham Rahmanian, Sadaf Dezfulian, Mahsa Eary, Aryan Rezaee, Romina Rajabi, Ramin Khorrami, Shokooh Salimimoghadam, Peng Hu, Mohsen Rashidi, Alireza Khodaei Ardakan, Yavuz Nuri Ertas, Kiavash Hushmandi. Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy. Translational oncology. 2024, 39: 101838Cited : 5Read More
- 24)- Natasa Matic, Lina Pettersson, Felicia Sellebjerg, Lina Lindberg, Karin Roberg, Emilia Wiechec. Prognostic value of hypoxia-responsive gene expression profile in patients diagnosed with head and neck squamous cell carcinoma. Translational oncology. 2024, 39: 101841Cited : 0Read More
